Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis

Veterinary Dermatology

Volumn 23, Issue 1, 2012, Pages

  Nuttall, Tim J ^a   Mcewan, Neil A ^a   Bensignor, Emmanuel ^b   Cornegliani, Luisa ^c   Löwenstein, Christine ^d   Rème, Christophe A ^e  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b CLINIQUE VÉTÉRINAIRE   (France)

^c Ambulatorio Veterinario Associato   (Italy)

^d Virbac SA ^*

^e Virbac SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; HYDROCORTISONE; HYDROCORTISONE ACEPONATE;

AEROSOL; ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; FEMALE; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AEROSOLS; ANIMALS; CYCLOSPORINE; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOG DISEASES; DOGS; FEMALE; HYDROCORTISONE; MALE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 84855342709     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2011.00992.x     Document Type: Article

References (36)

1. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Veterinary Immunology and Immunopathology 2001; 81: 147-51.
2. Olivry T. The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy. Veterinary Immunology and Immunopathology 2001; 81: 311-6.
3. Olivry T, DeBoer DJ, Favrot C et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology 2010; 21: 233-48.
4. Olivry T, Mueller RS. The International Task Force on Canine Atopic Dermatitis. Evidence-based veterinary dermatology: a systemic review of the pharmacotherapy of atopic dermatitis. Veterinary Dermatology 2003; 14: 121-46.
5. Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Veterinary Dermatology 2006; 17: 3-16.
6. Olivry T, Foster AP, Mueller RS et al. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Veterinary Dermatology 2010; 21: 4-22.
7. Olivry T, Rivierre C, Jackson HA et al. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Veterinary Dermatology 2002; 13: 77-87.
8. Steffan J, Alexander D, Brovedani F et al. Comparison of cyclosporineA with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial. Veterinary Dermatology 2003; 14: 1-9.
9. Olivry T, Steffan J, Fisch RD et al. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 2002; 221: 370-7.
10. Steffan J, Parks C, Seewald W. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Journal of the American Veterinary Medical Association 2005; 226: 1855-63.
11. Diesel A, Moriello KA. A busy clinician's review of cyclosporine. Veterinary Medicine 2008; 103: 266-71.
12. Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. American Journal of Clinical Dermatology 2002; 3: 47-58.
13. Schackert C, Korting HC, Schafer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterization of drugs with an increased benefit-risk ratio. Biodrugs 2000; 13: 267-77.
14. Nuttall TJ, Mueller RS, Bensignor E et al. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomized, double blind, placebo-controlled trial. Veterinary Dermatology 2009; 20: 191-8.
15. Rème CA, Dufour P. Effects of repeated topical application of a 0.0584% hydrocortisone aceponate spray on skin thickness in beagle dogs. International Journal of Applied Research in Veterinary Medicine 2010; 8: 1-6.
16. Bizikova P, Linder KE, Paps J et al. Effect of a novel topical diester glucocorticoid spray on immediate- and late-phase cutaneous allergic reactions in Maltese-beagle atopic dogs: a placebo-controlled study. Veterinary Dermatology 2010; 21: 70-9.
17. DeBoer DJ. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary Immunology and Immunopathology 2001; 81: 271-6.
18. Olivry T. New diagnostic criteria for canine atopic dermatitis. Veterinary Dermatology 2010; 21: 123-6.
19. Olivry T, Mueller R, Nuttall T et al. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis. Veterinary Dermatology 2008; 19: 115-9.
20. Faul F, Erdfelder E, Lang A-G et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 2007; 39: 175-91.
21. Hill PB, Lau P, Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Veterinary Dermatology 2007; 18: 301-8.
22. Lachin JM. Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations. Statistics in Medicine 1992; 11: 1151-70.
23. Thall PF, Lachin JM. Analysis of recurrent events - nonparametric methods for random-interval count data. Journal of the American Statistical Association 1988; 83: 339-47.
24. Wei LJ, Lachin JM. 2-sample asymptotically distribution-free tests for incomplete multivariate observations. Journal of the American Statistical Association 1984; 79: 653-61.
25. Colditz GA, Miller JN, Mosteller F. Measuring gain in the evaluation of medical technology. The probability of a better outcome. International Journal of Technology Assessment in Health Care 1988; 4: 637-42.
26. Fazakerley J, Nuttall T, Sales D et al. Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs. Veterinary Dermatology 2009; 20: 179-84.
27. Olivry T. The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy. Veterinary Immunology and Immunopathology 2001; 81: 317-22.
28. Marsella R, Olivry T. The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy. Veterinary Immunology and Immunopathology 2001; 81: 331-45.
29. Kimura T, Doi K. Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids. Toxicologic Pathology 1999; 27: 528-35.
30. Thomas RC, Logas D, Radosta L et al. Effects of a 1% hydrocortisone conditioner on haematological and biochemical parameters, adrenal function testing and cutaneous reactivity to histamine in normal and pruritic dogs. Veterinary Dermatology 1999; 10: 109-16.
31. Gross TL, Walder EJ, Ihrke PJ. Subepidermal bullous dermatosis due to topical corticosteroid therapy in dogs. Veterinary Dermatology 1997; 8: 127-31.
32. DeBoer DJ, Schafer JH, Salsbury CS et al. Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus. American Journal of Veterinary Research 2002; 63: 408-13.
33. Olivry T, Marsella R, Iwasaki T et al. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Veterinary Dermatology 2007; 18: 78-86.
34. Plant JD. Repeatability and reproducibility of numerical rating scales and visual analogue scales for canine pruritus severity scoring. Veterinary Dermatology 2007; 18: 190-1.
35. Favrot C, Linek M, Mueller R et al. Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners. Veterinary Dermatology 2010; 21: 63-9.
36. Linek M, Favrot C. Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners. Veterinary Dermatology 2010; 21: 456-62.